M. López-Trascasa

发表

The human complement factor H: functional roles, genetic variations and disease associations.

S. Rodríguez de Córdoba, J. Esparza-Gordillo, E. Goicoechea de Jorge, 2004, Molecular immunology.

Crucial residues in the carboxy-terminal end of C1 inhibitor revealed by pathogenic mutants impaired in secretion or function.

E. Couture-Tosi, M. López-Trascasa, E. Verpy, 1995, The Journal of clinical investigation.

Complement as a diagnostic tool in immunopathology.

M. López-Trascasa, P. Sánchez-Corral, J. R. Regueiro, 2018, Seminars in cell & developmental biology.

Acquired partial lipodystrophy and C3 glomerulopathy: Dysregulation of the complement system as a common mechanism

M. López-Trascasa, F. Corvillo, 2018 .

Laboratory guidelines for the diagnosis and follow-up of patients with monoclonal gammopathies

M. López-Trascasa, L. Villar, C. Juárez, 2016 .

C5 complement deficiency in a Spanish family. Molecular characterization of the double mutation responsible for the defect.

M. López-Trascasa, G. Fontán, E. Delgado-Cerviño, 2005, Molecular immunology.

Molecular characterization of Complement Factor I deficiency in two Spanish families.

M. López-Trascasa, P. Sánchez-Corral, G. Fontán, 2008, Molecular immunology.

Complement factor I deficiency associated with recurrent meningitis coinciding with menstruation.

M. López-Trascasa, J. Arpa, G. Fontán, 2001, Archives of neurology.

Antinucleosome antibodies as a marker of active proliferative lupus nephritis.

M. López-Trascasa, S. Moll, E. Potlukova, 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.

High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis.

S. Sadallah, V. Tesar, M. López-Trascasa, 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Complement factor H, FHR-3 and FHR-1 variants associate in an extended haplotype conferring increased risk of atypical hemolytic uremic syndrome.

S. Rodríguez de Córdoba, M. López-Trascasa, P. Sánchez-Corral, 2015, Molecular Immunology.

Eculizumab in dense-deposit disease after renal transplantation

S. Rodríguez de Córdoba, M. López-Trascasa, A. Sánchez-Moreno, 2014, Pediatric Nephrology.

Anti-factor H antibody affecting factor H cofactor activity in a patient with dense deposit disease

S. Rodríguez de Córdoba, M. López-Trascasa, P. Sánchez-Corral, 2012, Clinical kidney journal.

Laboratory guidelines for the diagnosis of patients with cryoglobulinemic syndrome

M. López-Trascasa, M. Hernández González, E. Moga Naranjo, 2019 .

Complement Factor D (adipsin) Levels Are Elevated in Acquired Partial Lipodystrophy (Barraquer–Simons syndrome)

F. Villarroya, F. Santini, G. Ceccarini, 2021, International journal of molecular sciences.

Immunological features of patients affected by Barraquer-Simons syndrome

F. Santini, G. Ceccarini, M. López-Trascasa, 2020, Orphanet Journal of Rare Diseases.

Hereditary and acquired angioedema: Problems and progress: Proceedings of the third C1 esterase inhibitor deficiency workshop and beyond

A. Tordai, L. Truedsson, M. López-Trascasa, 2004, Journal of Allergy and Clinical Immunology.

An ELISA assay with two monoclonal antibodies allows the estimation of free factor H and identifies patients with acquired deficiency of this complement regulator.

M. López-Trascasa, P. Sánchez-Corral, S. R. Córdoba, 2014, Molecular immunology.

O24Complement factor H haplotypes and copy number variations of the factor H-related genes in renal and ocular disorders

M. López-Trascasa, P. Sánchez-Corral, S. R. Córdoba, 2007 .

Autoantibodies against alternative complement pathway proteins in renal pathologies.

M. López-Trascasa, P. Nozal, 2016 .

Cellular Adhesion Mediated by Factor J, a Complement Inhibitor

E. López-Granados, M. López-Trascasa, M. Fresno, 1998, The Journal of Biological Chemistry.

Autoantibodies against complement receptor 1 (CD35) in SLE, liver cirrhosis and HIV‐infected patients

C. Hess, S. Sadallah, M. López-Trascasa, 2003, Clinical and experimental immunology.

The mechanism of loss of CR1 during maturation of erythrocytes is different between factor I deficient patients and healthy donors.

S. Sadallah, J. Schifferli, M. López-Trascasa, 2002, Blood cells, molecules & diseases.

Consensus statement on the diagnosis, management, and treatment of angioedema mediated by bradykinin. Part II. Treatment, follow-up, and special situations.

M. López-Trascasa, M. Pedrosa, C. Marcos, 2011, Journal of investigational allergology & clinical immunology.

Extravascular hemolysis and complement consumption in Paroxysmal Nocturnal Hemoglobinuria patients undergoing eculizumab treatment.

S. Rodríguez de Córdoba, M. López-Trascasa, A. Villegas, 2017, Immunobiology.

Autoantibodies Against Perilipin 1 as a Cause of Acquired Generalized Lipodystrophy

M. López-Trascasa, D. Araújo-Vilar, A. López-Lera, 2018, Front. Immunol..

Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome

B. Paul Morgan, Pilar Sánchez-Corral, Claire L. Harris, 2007, Proceedings of the National Academy of Sciences.

The molecular and structural bases for the association of complement C3 mutations with atypical hemolytic uremic syndrome

S. Rodríguez de Córdoba, M. López-Trascasa, P. Sánchez-Corral, 2015, Molecular immunology.

The molecular and structural bases for the association of complement C 3 mutations with atypical hemolytic uremic syndrome

M. López-Trascasa, P. Sánchez-Corral, B., 2015 .

Complement factor I deficiency: a not so rare immune defect. Characterization of new mutations and the first large gene deletion

P. Soler-Palacín, M. López-Trascasa, C. Cámara, 2012, Orphanet Journal of Rare Diseases.

Atypical hemolytic uremic syndrome in the Tunisian population

G. Lefranc, M. López-Trascasa, P. Sánchez-Corral, 2011, International Urology and Nephrology.

Successful Renal Transplantation in a Patient with Atypical Hemolytic Uremic Syndrome Carrying Mutations in Both Factor I and MCP

M. López-Trascasa, P. Sánchez-Corral, J. Torras, 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

SERPING1 Variants and C1-INH Biological Function: A Close Relationship With C1-INH-HAE

S. Cichon, M. López-Trascasa, J. Pesquero, 2022, Frontiers in Allergy.

HIV‐1 induced generation of C5a attracts immature dendriticcells and promotes infection of autologous T cells

M. López-Trascasa, M. Dierich, C. Gassner, 2007, European journal of immunology.

Human plasma C3 is essential for the development of memory B, but not T, lymphocytes.

S. Tangye, M. Kolev, S. Rodríguez de Córdoba, 2017, The Journal of allergy and clinical immunology.

Heterogeneity but individual constancy of epitopes, isotypes and avidity of factor H autoantibodies in atypical hemolytic uremic syndrome.

M. López-Trascasa, P. Sánchez-Corral, T. Jokiranta, 2016, Molecular immunology.

Eculizumab in the treatment of atypical hemolytic uremic syndrome in infants.

M. López-Trascasa, G. Ariceta, B. Arrizabalaga, 2012, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Disease-modifying factors in hereditary angioedema: an RNA expression-based screening

A. Dopazo, M. López-Trascasa, A. López-Lera, 2013, Orphanet Journal of Rare Diseases.

First case of homozygous C1 inhibitor deficiency.

M. López-Trascasa, P. Gamboa, O. Roche, 2006, The Journal of allergy and clinical immunology.

Polyclonal autoantibodies against C1 inhibitor in a case of acquired angioedema.

M. López-Trascasa, M. Reche, M. C. Lopez-serrano, 2002, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Newborn Screening for Presymptomatic Diagnosis of Complement and Phagocyte Deficiencies

P. Nilsson, J. Schwenk, Y. Mizuno, 2020, Frontiers in Immunology.

Analysis of SERPING1 expression on hereditary angioedema patients: quantitative analysis of full-length and exon 3 splicing variants.

M. López-Trascasa, A. López-Lera, R. M. de la Cruz, 2012, Immunology letters.

Complement component C7 deficiency in two Spanish families

M. López-Trascasa, R. Luque, A. Nunez‐roldan, 2004, Immunology.

Complement component C7 deficiency in a Spanish family

M. López-Trascasa, A. Alarcon, A. Nunez‐roldan, 2003, Clinical and experimental immunology.

A novel nonsense mutation at Glu-631 in a Spanish family with complement component 7 deficiency

M. López-Trascasa, T. Horiuchi, J. Ferrer, 1999, Journal of Human Genetics.

Common and rare genetic variants of complement components in human disease

M. López-Trascasa, R. Bayarri-Olmos, S. D. de Córdoba, 2018, Molecular immunology.

Characterization of complement factor H-related (CFHR) proteins in plasma reveals novel genetic variations of CFHR1 associated with atypical hemolytic uremic syndrome.

M. López-Trascasa, P. Sánchez-Corral, S. D. de Córdoba, 2009, Blood.

Expression of the SERPING1 gene is not regulated by promoter hypermethylation in peripheral blood mononuclear cells from patients with hereditary angioedema due to C1-inhibitor deficiency

M. López-Trascasa, I. Ibáñez de Cáceres, O. Pernía, 2014, Orphanet Journal of Rare Diseases.

Autoantibodies in patients with IgA and IgG2 deficiencies

M. López-Trascasa, Antonio Ferreira, R. Álvarez-Doforno, 1991, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

Anti-IgA antibodies in selective IgA deficiency and in primary immunodeficient patients treated with gamma-globulin.

M. López-Trascasa, M. C. García Rodríguez, A. Ferreira, 1988, Clinical immunology and immunopathology.

Complement Interaction with Trypanosomatid Promastigotes in Normal Human Serum

M. López-Trascasa, M. Domínguez, I. Moreno, 2002, The Journal of experimental medicine.

Hereditary angioedema due to C1 inhibitor deficiency: patient registry and approach to the prevalence in Spain.

M. López-Trascasa, O. Roche, D. Callejo, 2005, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Clinical Pattern and Acute and Long-term Management of Hereditary Angioedema Due to C1-Esterase Inhibitor Deficiency.

M. López-Trascasa, M. Pedrosa, M. García-Ara, 2015, Journal of investigational allergology & clinical immunology.

Functional C1-inhibitor diagnostics in hereditary angioedema: assay evaluation and recommendations.

H. Joller-jemelka, L. Truedsson, C. Hack, 2008, Journal of immunological methods.

Detection of C1 inhibitor (SERPING1/C1NH) mutations in exon 8 in patients with hereditary angioedema: evidence for 10 novel mutations

E. López-Granados, M. López-Trascasa, O. Roche, 2002, Human mutation.

Clinical, biochemical, and genetic characterization of type III hereditary angioedema in 13 Northwest Spanish families.

M. López-Trascasa, C. Marcos, T. Liñares, 2012, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

A new case of homozygous C1-inhibitor deficiency suggests a role for Arg378 in the control of kinin pathway activation.

M. López-Trascasa, C. Drouet, A. López-Lera, 2010, The Journal of allergy and clinical immunology.

Hereditary angioedema: The mutation spectrum of SERPING1/C1NH in a large Spanish cohort

M. López-Trascasa, M. Tosi, O. Roche, 2005, Human mutation.

SERPING1 mutation update: Mutation spectrum and C1 Inhibitor phenotypes

M. López-Trascasa, C. Gaboriaud, Ineke G A Wagenaar-Bos, 2019, Human mutation.

Targeted next-generation sequencing for the molecular diagnosis of hereditary angioedema due to C1-inhibitor deficiency.

M. López-Trascasa, H. Farkas, M. Maurer, 2018, Gene.

SERPING1 mutations in 59 families with hereditary angioedema.

M. López-Trascasa, O. Roche, A. López-Lera, 2011, Molecular immunology.

Abstracts from the 10th C1-inhibitor deficiency workshop

William H. Yang, A. Szilágyi, M. Margaglione, 2017, Allergy, Asthma & Clinical Immunology.

C1 inhibitor function using contact‐phase proteases as target: evaluation of an innovative assay

M. López-Trascasa, C. Drouet, F. Defendi, 2015, Allergy.

Consensus statement on the diagnosis, management, and treatment of angioedema mediated by bradykinin. Part I. Classification, epidemiology, pathophysiology, genetics, clinical symptoms, and diagnosis.

M. López-Trascasa, M. Pedrosa, C. Marcos, 2011, Journal of investigational allergology & clinical immunology.

Metallopeptidase activities in hereditary angioedema: effect of androgen prophylaxis on plasma aminopeptidase P.

M. López-Trascasa, D. Moneret-vautrin, J. Quesada, 2008, The Journal of allergy and clinical immunology.

Hereditary angioedema caused by the p.Thr309Lys mutation in the F12 gene: a multifactorial disease.

M. López-Trascasa, C. Drouet, N. Prior, 2013, The Journal of allergy and clinical immunology.

Thrombin in the Activation of the Fluid Contact Phase in Patients with Hereditary Angioedema Carrying the F12 P.Thr309Lys Variant

M. López-Trascasa, J. Emsley, J. Corral, 2021, Clinical Reviews in Allergy & Immunology.

The FXII c.-4T>C Polymorphism as a Disease Modifier in Patients With Hereditary Angioedema Due to the FXII p.Thr328Lys Variant

M. López-Trascasa, J. Emsley, J. Corral, 2020, Frontiers in Genetics.

Complement Study Versus CINH Gene Testing for the Diagnosis of Type I Hereditary Angioedema in Children

M. López-Trascasa, M. Pedrosa, A. López-Lera, 2015, Journal of Clinical Immunology.

Novel homozygous variants in the SERPING1 gene in two Turkish families with hereditary angioedema of recessive inheritance

M. López-Trascasa, H. Onay, A. López-Lera, 2020, Immunology and cell biology.

Acquired Angioedema With Anti-C1-inhibitor Autoantibodies During Assisted Reproduction Techniques.

M. López-Trascasa, T. Caballero, J. Gil Herrera, 2018, Journal of investigational allergology & clinical immunology.

Successful use of rituximab in acquired C1 inhibitor deficiency secondary to Sjögren’s syndrome

M. López-Trascasa, N. Ortego-Centeno, J. Callejas-Rubio, 2008, Lupus.

Elevated factor J levels in synovial fluid from patients with inflammatory arthropathies.

M. López-Trascasa, A. Balsa, D. Pascual‐Salcedo, 1997, Immunopharmacology.

Nephritic Factors: An Overview of Classification, Diagnostic Tools and Clinical Associations

M. Okrój, M. López-Trascasa, P. Sánchez-Corral, 2019, Front. Immunol..

Elevated factor H-related protein 1 and factor H pathogenic variants decrease complement regulation in IgA nephropathy.

S. Rodríguez de Córdoba, E. Goicoechea de Jorge, M. López-Trascasa, 2017, Kidney international.

Self-Damage Caused by Dysregulation of the Complement Alternative Pathway: Relevance of the Factor H Protein Family

M. López-Trascasa, P. Sánchez-Corral, M. Józsi, 2018, Front. Immunol..

Autoantibodies to complement components in C3 glomerulopathy and atypical hemolytic uremic syndrome.

M. López-Trascasa, P. Sánchez-Corral, S. Reuter, 2014, Immunology letters.

Factor J, an inhibitor of the classical and alternative complement pathway, does not inhibit esterolysis by factor D.

M. López-Trascasa, R. González-Muñiz, M. Jiménez-Clavero, 1996, Biochimica et biophysica acta.

Cell surface molecules related to factor J in human lymphoid cells and cell lines.

M. López-Trascasa, M. Jiménez-Clavero, C. Gamallo, 1995, Journal of immunology.

The inhibitory effect of factor J on the alternative complement pathway.

M. López-Trascasa, M. Jiménez-Clavero, C. González-Rubio, 1994, The Journal of biological chemistry.

Factor J, a human inhibitor of complement C1, is a cationic, highly glycosylated protein.

M. López-Trascasa, M. Jiménez-Clavero, C. González-Rubio, 1994, Immunology letters.

Factor J, an inhibitor of the complement classical pathway: the quantitation by an ELISA inhibition assay in normal human serum.

M. López-Trascasa, M. Jiménez-Clavero, C. González-Rubio, 1994, Clinical biochemistry.

Factor J: isolation and characterization of a new polypeptide inhibitor of complement C1.

M. López-Trascasa, D. Bing, A. Nicholson-Weller, 1989, The Journal of biological chemistry.

Serum properdin consumption as a biomarker of C5 convertase dysregulation in C3 glomerulopathy

S. Rodríguez de Córdoba, M. López-Trascasa, F. Corvillo, 2016, Clinical and experimental immunology.

Insights into hemolytic uremic syndrome: segregation of three independent predisposition factors in a large, multiple affected pedigree.

J. Esparza-Gordillo, M. López-Trascasa, P. Sánchez-Corral, 2006, Molecular immunology.

Molecular defects of the C7 gene in two patients with complement C7 deficiency

M. López-Trascasa, C. Rieubland, P. Bart, 2006, Immunology.

Combined total deficiency of C7 and C4B with systemic lupus erythematosus (SLE)

M. López-Trascasa, A. Arnaiz-Villena, J. Martinez-Laso, 1992, Clinical and experimental immunology.

C7 Deficiency and Meningococcal Infection Susceptibility in Two Spanish Families

M. López-Trascasa, A. Nunez‐roldan, S. Barroso, 2010, Scandinavian journal of immunology.

Quantitation of C2 by rocket immunoelectrophoresis in 120 pathological sera.

M. López-Trascasa, C. Blanc, D. Prevot, 1981, Pathologie-biologie.

Predisposition to atypical hemolytic uremic syndrome involves the concurrence of different susceptibility alleles in the regulators of complement activation gene cluster in 1q32.

A. Buil, S. Rodríguez de Córdoba, J. Esparza-Gordillo, 2005, Human molecular genetics.

Structural and functional characterization of factor H mutations associated with atypical hemolytic uremic syndrome.

D. Pérez-Caballero, M. López-Trascasa, P. Sánchez-Corral, 2002, American journal of human genetics.

Receptors for complement components in inflammation

M. López-Trascasa, C. Blanc, A. Cattaneo, 1983, Agents and Actions.

AbstractIsolation and characterization of a biologically active C2 derived oligopeptide

M. López-Trascasa, C. Blanc, Y. Blouquit, 1982 .

Complement factor H variants I890 and L1007 while commonly associated with atypical hemolytic uremic syndrome are polymorphisms with no functional significance.

M. López-Trascasa, P. Sánchez-Corral, S. D. de Córdoba, 2012, Kidney international.

Utility of oligoclonal IgG band detection for MS diagnosis in daily clinical practice.

X. Montalban, J. Yagüe, M. López-Trascasa, 2011, Journal of immunological methods.

Deregulated cellular circuits driving immunoglobulins and complement consumption associate with the severity of COVID‐19 patients

F. Sánchez‐Madrid, M. López-Trascasa, I. González-Álvaro, 2020, medRxiv.

Sensitive and specific assays for C3 nephritic factors clarify mechanisms underlying complement dysregulation

L. Truedsson, M. López-Trascasa, B. Morgan, 2012, Kidney international.

Human C3 mutation reveals a mechanism of dense deposit disease pathogenesis and provides insights into complement activation and regulation.

S. Rodríguez de Córdoba, M. López-Trascasa, M. Heurich, 2010, The Journal of clinical investigation.

Determination of C3 nephritic factor activity by a microassay based on the peroxidase-like activity of the heme group.

M. López-Trascasa, A. Domingo, M. A. Marín, 1990, Clinical biochemistry.

Clustering of missense mutations in the C-terminal region of factor H in atypical hemolytic uremic syndrome.

D. Pérez-Caballero, S. Rodríguez de Córdoba, M. López-Trascasa, 2001, American journal of human genetics.

Testing the Activity of Complement Convertases in Serum/Plasma for Diagnosis of C4NeF-Mediated C3 Glomerulonephritis

A. Blom, M. Okrój, S. Rodríguez de Córdoba, 2016, Journal of Clinical Immunology.

A novel method for direct measurement of complement convertases activity in human serum

E. Volokhina, A. Blom, M. Okrój, 2014, Clinical and experimental immunology.

Case report: lupus nephritis with autoantibodies to complement alternative pathway proteins and C3 gene mutation

M. López-Trascasa, S. D. de Córdoba, J. Martínez-Ara, 2015, BMC Nephrology.

Interaction of C3 nephritic factor (NEF) with erythrocyte membranes complement-independent binding to sheep and patients' erythrocytes.

M. López-Trascasa, M. A. Marín, G. Fontán, 1991, Molecular immunology.

Eculizumab long-term therapy for pediatric renal transplant in aHUS with CFH/CFHR1 hybrid gene

S. Rodríguez de Córdoba, M. López-Trascasa, P. Sánchez-Corral, 2013, Pediatric Nephrology.

C3 nephritic factor determination. A comparison between two methods.

M. López-Trascasa, M. A. Marín, G. Fontán, 1987, Journal of immunological methods.

Evidence of an immediate hypersensitivity mechanism in systemic lupus erythematosus.

M. López-Trascasa, J. Egido, C. Lahoz, 1980, Annals of the rheumatic diseases.

Evidence ofan immediate hypersensitivity mechanism in systemic lupus erythematosus 313 BASOPHIL DEGRANULATION UTILISING SONICATED DNA

M. López-Trascasa, J. Egido, M. Crespo, 2022 .

011Complement profile and autoantibodies against adipocytes on acquired lipodystrophies

M. López-Trascasa, F. Corvillo, S. Garrido, 2017 .

Measurement of complement convertases in serum

E. Volokhina, A. Blom, M. López-Trascasa, 2014 .

Functional analysis in serum from atypical Hemolytic Uremic Syndrome patients reveals impaired protection of host cells associated with mutations in factor H.

S. Rodríguez de Córdoba, M. López-Trascasa, P. Sánchez-Corral, 2004, Molecular immunology.

Interaction between C3 nephritic factor and erythrocyte membranes. Presence of nephritic factor in patients' erythrocytes.

M. López-Trascasa, M. A. Marín, G. Fontán, 1988, Complement.

Case Report: Combined Liver-Kidney Transplantation to Correct a Mutation in Complement Factor B in an Atypical Hemolytic Uremic Syndrome Patient

S. Rodríguez de Córdoba, M. López-Trascasa, P. Sánchez-Corral, 2021, Frontiers in Immunology.

Atypical Hemolytic Uremic Syndrome-Associated Variants and Autoantibodies Impair Binding of Factor H and Factor H-Related Protein 1 to Pentraxin 3

S. Rodríguez de Córdoba, M. López-Trascasa, P. Sánchez-Corral, 2012, The Journal of Immunology.

Association of anti-C1 inhibitor and anti-protein S antibodies in a patient with primary antiphospholipid syndrome

M. López-Trascasa, M. Sorice, A. Capozzi, 2009, Lupus.

Mechanisms Involved in Hypersensitivity Reactions to Polysulfone Hemodialysis Membranes

M. López-Trascasa, R. Selgas, T. Bellón, 2017, Artificial organs.

Acquired C1 esterase inhibitor deficiency (multiple letters)

M. López-Trascasa, S. Markovic, M. Cicardi, 2000 .

Mutations in proteins of the alternative pathway of complement and the pathogenesis of atypical hemolytic uremic syndrome.

M. López-Trascasa, P. Sánchez-Corral, S. D. de Córdoba, 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.

IN TRANSLATION Mutations in Proteins of the Alternative Pathway of Complement and the Pathogenesis of Atypical Hemolytic Uremic Syndrome

M. López-Trascasa, P. Sánchez-Corral, S. R. Córdoba, 2008 .

Molecular characterization of three new mutations causing C5 deficiency in two non-related families.

M. López-Trascasa, A. López-Lera, S. Garrido, 2009, Molecular immunology.

Requirements for the production of high-titre C3 nephritic factor (NEF) antibody in vitro.

M. López-Trascasa, M. A. Marín, G. Fontán, 1992, Immunology.

Paramagnetic Contrast Media : Hypersensitivity and Cross-Reactivity

M. López-Trascasa, T. Caballero, Caballero, 2018 .

Modulation of C4b-binding protein isoforms during the acute phase response caused by orthopedic surgery.

S. Rodríguez de Córdoba, M. López-Trascasa, L. Munuera, 1997, Haemostasis.

Complement factor I deficiency: a not so rare immune defect. Characterization of new mutations and the first large gene deletion

P. Soler-Palacín, M. López-Trascasa, F. Leturcq, 2012, Orphanet Journal of Rare Diseases.

Recombinational biases in the rearranged C1-inhibitor genes of hereditary angioedema patients.

D. Stoppa-Lyonnet, M. López-Trascasa, C. Moraine, 1991, American journal of human genetics.

Angioedema and transient acquired C1 inhibitor functional deficiency in HIV infection: case report.

M. López-Trascasa, J. Arribas, M. Reche, 2002, AIDS (London).

Complement factor I deficiency: a not so rare immune defect. Characterization of new mutations and the first large gene deletion

P. Soler-Palacín, M. López-Trascasa, F. Leturcq, 2012, Orphanet Journal of Rare Diseases.

Atypical Hemolytic Uremic Syndrome-Associated Variants and Autoantibodies Impair Binding of Factor H and Factor H-Related Protein 1 to Pentraxin 3

S. Rodríguez de Córdoba, M. López-Trascasa, P. Sánchez-Corral, 2012, The Journal of Immunology.

Autoantibodies to complement components in C3 glomerulopathy and atypical hemolytic uremic syndrome.

M. López-Trascasa, P. Sánchez-Corral, S. Reuter, 2014, Immunology letters.

Complement factor H, FHR-3 and FHR-1 variants associate in an extended haplotype conferring increased risk of atypical hemolytic uremic syndrome.

S. Rodríguez de Córdoba, M. López-Trascasa, P. Sánchez-Corral, 2015, Molecular immunology.

71Mutations in complement factor B are associated with atypical hemolytic uremic syndrome

J. Esparza-Gordillo, M. López-Trascasa, P. Sánchez-Corral, 2007 .

Heterogeneity but individual constancy of epitopes, isotypes and avidity of factor H autoantibodies in atypical hemolytic uremic syndrome.

M. López-Trascasa, P. Sánchez-Corral, T. Jokiranta, 2016, Molecular immunology.

Mutations in proteins of the alternative pathway of complement and the pathogenesis of atypical hemolytic uremic syndrome.

M. López-Trascasa, P. Sánchez-Corral, M. Melgosa, 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Complement Study Versus CINH Gene Testing for the Diagnosis of Type I Hereditary Angioedema in Children

M. López-Trascasa, M. Pedrosa, A. López-Lera, 2015, Journal of Clinical Immunology.

Rothmund-Thomson syndrome and glomerulonephritis in a homozygous C1q-deficient patient due to a Gly164Ser C1qC mutation.

M. López-Trascasa, Alberto López-Lera, Juan M Torres-Canizales, 2014, The Journal of investigative dermatology.